Azitra Inc

AZTRAMEX • USD
0.63 USD
↗ 0.02 (3.06%)AT CLOSE (03:59 PM EST)
0.60
↘ 0.02 (3.83%)
POST MARKET (AS OF 07:58 PM EST)
Post Market
AS OF 07:58 PM EST
0.60
↘ 0.02 (3.83%)
🔴Market: CLOSED

AZTR is currently priced at $0.63. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, AZTR appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$0.60
High?$0.65
Low?$0.56
Prev. Close?$0.61
Volume?162.3K
Avg. Volume?5.9M
VWAP?$0.60
Rel. Volume?0.03x
Bid / Ask
Bid?$0.56 × 100
Ask?$0.63 × 100
Spread?$0.07
Midpoint?$0.60
Valuation & Ratios
Market Cap?3.7M
Shares Out?6.1M
Float?49.3M
Float %?81.3%
P/E Ratio?N/A
P/B Ratio?0.84
EPS?-$2.06
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
Employees
13
Market Cap
3.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2023-06-16
Address
21 BUSINESS PARK DRIVE, SUITE 6
BRANFORD, CT 06405
Phone: (203) 489-0183
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?-23.29Distress
Confidence?43%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.62%Low
Short Interest?305.8K
Days to Cover?1.0
Free Float49.3M
Avg Daily Volume14.6M
Settlement Date2026-10-30
Financial Health
Current Ratio?3.11Strong
Quick Ratio?3.11Strong
Cash Ratio?2.44Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.84CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
0.0CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-283.3%WEAK▾
ROA?
S&P
3
-208.6%WEAK▾
Cash Flow & Enterprise
FCF?$-11645569
Enterprise Value?$-53845
Fundamentals ratios updated end of day